One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in ...

Q4 2024 Earnings Call Transcript March 27, 2025 ADC Therapeutics SA beats earnings expectations. Reported EPS is $-0.29, ...

Nischal HP discusses the critical role of data credibility in combating greenwashing and enabling effective climate action. He shares how technology can be used to create verifiable data on carbon ...

In education, learning becomes more impactful when placed in a meaningful context. Traditional classrooms often lack the resources to simulate real-world situations. However, by using animation tools ...

Q4 2024 Earnings Conference Call March 25, 2025 9:00 AM ETCompany ParticipantsMikkel Gleerup - CEOPeter Brogaard Hansen - ...

Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient populationUBX1325 was ...

Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All ...

NYDIG, a leading bitcoin and power firm, today announced it has entered into a definitive agreement to acquire Crusoe's Bitcoin mining operations.  As part of the transaction, NYDIG will acquire over ...

Intermap Technologies Corporation ( OTCQB:ITMSF) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ET Sean Peasgood - Sophic Capital, Investor Relations Patrick Blott - Chairman and Chief ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results ...